chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few hours after the vaccine shot I started feeling tired and sore all over.  I also had stomach pain.  Three days later on Saturday morning 6 Feb 2021 I noticed a bad rash on my back, under my left shoulder, and on the middle of my chest.  I went to my doctor office later that morning and they told me I had Shingles.  They put me on an anti-viral medication called Valacyclovir.  (1 gram tablet every 8 hours for seven days.)
Chest tightness with SOB and tachycardia (128bpm) after second dose of Covid-19 vaccine with recent Covid-19 infection of 12/8/21
COVID positive home test on 02Aug2022; COVID positive home test on 02Aug2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02Aug2022, outcome "unknown" and all described as "COVID positive home test on 02Aug2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Aug2022) Positive, notes: COVID positive home test on 22Aug2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200036717 same reporter/ drug/ event, different patient;
About 1 hour after adm the vaccine co school based clinic child presented with hives arms and hand. Denies shortness of breath. School nurse adm. 12.5 mg BENADRYL no further problems.
Patient having 'stopped breathing'; had a little trouble swallowing.; This spontaneous report has been received from physician, regarding to a 3-month-old infant male patient. The patient's historical conditions included premature baby and respiratory arrest. His concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.   On 29-JUL-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), oral liquid, orally administered, for prevention of rotavirus gastroenteritis (strength, dose, lot number and expiration date were not provided).   On 29-JUL-2022, the patient developed a little trouble swallowing (swallowing difficult) the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), and he had stopped breathing (respiratory arrest). Additionally, the patient's mom, confirmed how patient did this all the time. The outcome of swallowing difficult and respiratory arrest was not provided.  The causal relationship between aforementioned events and the suspect therapy was not provided.  Upon internal review, the event respiratory arrest was considered to be medically significant.
Patient  was  scared  of  Needles; Experienced Syncopy & Fainted about 5 min.  after the dose given!  Layed on floor   with feet up for about 5 min. Sat upright  for about 30 min & seemed fine. Walked to   car wife was a nurse & with him.
Pt. seen Wed. 4-2-08, given Pneumovax inj., by Thurs. night her arm was fiery red, red rash, warm to the touch, and sore.  No tx.
Pt felt hot within 5 minutes after the injection.  Then became diaphoretic, pale,  became lethargic and sleepy for 1 hour.
Chills, Headache, teeth hurt and exhausted for 50 hours. It was worse then when I had Covid.
The patient reports that the following morning, January 13th, after receiving the second dose of the vaccine, at the injection site, her arm was red, swollen, inflammed, and had peeling skin around it. Additionally, she reports that at the injection site, it was firm/hard, hot, painful, and itching. The patient saw FNP, on January 14th, and was administered an IM dose of cortisone, and prescriptions for Keflex and a Medrol dose pack. The patient was instructed to return to Doctor's office on January 15th to allow her to observe the site again.
stiff neck, glazed eyes,t100.1 x 3 days, seen in ER-mom states rxn to vax ER report states viral;
17DEC98 mom called hlth dept pt devel a firm red raised rash on back, trunk, face;pt irritable, vaginal rash-diaper area;rash is crusted over;
NO AVERSE SIDE EFFECTS KNOWN. Patient is 9 years old and got the above 12 years old vaccination. Patient weighs more than 100 Pounds
Almost passed out; Dizziness; Feel flushed; Joints feel inflamed; Soreness in her arm; Chills; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Almost passed out), DIZZINESS (Dizziness), FLUSHING (Feel flushed), ARTHRITIS (Joints feel inflamed) and PAIN IN EXTREMITY (Soreness in her arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (arthritis in right arm).    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 26-Feb-2021, the patient experienced PRESYNCOPE (Almost passed out), DIZZINESS (Dizziness), FLUSHING (Feel flushed), ARTHRITIS (Joints feel inflamed), PAIN IN EXTREMITY (Soreness in her arm) and CHILLS (Chills). At the time of the report, PRESYNCOPE (Almost passed out), DIZZINESS (Dizziness), FLUSHING (Feel flushed), ARTHRITIS (Joints feel inflamed) and CHILLS (Chills) outcome was unknown and PAIN IN EXTREMITY (Soreness in her arm) and VACCINATION SITE PAIN (soreness at the injection site) had not resolved.            No concomitant medications reported. Treatment included Tylenol
Right after I went to sleep around 12:30AM EST on 4/5 I noticed there was no feeling in my left leg - lasted 30 minutes - then I was able to walk on it but did not want to put full weight on it - went to urgent care clinic at 11:30 am est on 4/5 and they referred me to ER. Arrived at ER around 12:30 pm est on 4/5 (I walked into both places without assistance). They gave me Eloquis at hospital and I had slightly higher blood pressure than normal. Was discharged late in day on 4/6 around 5pm est. They gave me neuro eval every 2-3 hours and pulled blood constantly. They decided to start me on Crestor at hospital as well - was already on finofibrate, stopped fiofibrate aand fish oil and baby aspirin once I returned home
No addittional adverse effects reported; MMR II that underwent temperature excursions was administered; This spontaneous report was received from an unspecified reporter, concerning a patient of unknown age and gender. Information about pertinent medical history, concurrent conditions, concomitant medications and drug allergies or reactions was not provided.   On 26-OCT-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot number T033814, with expiration date reported and validated as 05-OCT-2022 (strength, exact dose, vaccination schedule, route of administration, anatomical site of injection were not reported) for prophylaxis that underwent a temperature excursion. No additional adverse effect reported.   The vaccine underwent a temperature above 9 degrees Celsius (12.4 degrees Celsius), for a timeframe of 0 hours 53 minutes and 0 seconds, above 9 degrees Celsius (9.6 degrees Celsius) for 0 hours and 34 minutes and 0 seconds, above 9 degrees Celsius (9.5 degrees Celsius) for 0 hours 23 minutes and 0 seconds, above 9 degrees Celsius (8.5 degrees Celsius) for 0 hours 9 minutes and 0 seconds. No previous temperature excursion (product storage error).; Sender's Comments:  US-009507513-2112USA006870: US-009507513-2112USA007442: US-009507513-2112USA007443: US-009507513-2112USA007429: US-009507513-2112USA007428: US-009507513-2112USA007430: US-009507513-2112USA007431: US-009507513-2112USA007432: US-009507513-2112USA007433: US-009507513-2112USA007434: US-009507513-2112USA007435: US-009507513-2112USA007440: US-009507513-2112USA007441: US-009507513-2112USA007444: US-009507513-2112USA007445: US-009507513-2112USA007446: US-009507513-2112USA007447: US-009507513-2112USA007427: US-009507513-2112USA007426: US-009507513-2112USA007425: US-009507513-2112USA007436:
Several days after getting ZOSTAVAX pt. arm where shot was administered started to swell and feel uncomfortable.
mom states soon p/vax pt c/o stomachache (abd pains) which progressed throughout the day;c/o strawberry rash noted 1inch from inj site;
Initial report received on 08 July 2011 from a literature citation (abstract). The following is verbatim per the abstract: "We reviewed reports to VAERS to determine the clinical and microbiologic characteristics of serious injection site abscesses following vaccination. Methods: VAERS is a passive surveillance system for collecting adverse events following vaccination. We reviewed reports coded as "abscess" or "sterile abscess" submitted from 7/90 to 4/01 and described by the reporter as serious (causing life-threatening illness, hospitalization or disability). To meet the case definition, reports described localized soft tissue collection of fluid at the injection site following vaccination, with spontaneous or surgical drainage or fluid collection diagnosed by imaging. Results: 69 reports met the case definition. Of 61 cases for which the associated vaccine could be identified, abscesses occurred at injection sites of DTP, DTaP or DTP/DTaP- based combinations in 32 and hepatitis B vaccine in 11 reports, 66 cases required hospitalization and 51 reported needle aspiration, surgical drainage or excision. Fever was reported in 16 cases. There were 9 reports of recurrent abscess at the same site after initial resolution and 5 reports of new abscess formation following subsequent vaccination. Median age was 0.8 yrs (range: birth-78) and 38 were females. Cultures were noted in 35 reports with organisms identified in 20, no growth reported in 12, and unspecified results in 3. For 31 reports, no information was provided on whether cultures were obtained. Organisms included S. aureus (11 reports), Group A streptococci (7), S. epidermidis (2), S. pneumoniae (2), unspecified streptococci (2), unspecified staphylococci (1), A. radiobacter (1), H. parainfluenzae (1), unspecified enterococci (1) and M. chelonae (1). 9 reports mentioned 2 organisms. Discussion: Abscesses after vaccination have been associated with hospitalization, surgical drainage and fever. Cultures of abscesses were often not reported or were negative. When reported, the majority of isolated organisms were common skin flora. A standardized approach to evaluate abscesses is warranted to better delineate etiology and to guide possible prevention efforts." Outcomes were not reported. Documents held by sender: None.
Redness and swelling of about 4 inches in diameter under area where vaccine was administered. Area is hot to the touch, painful, and itchy.
SERIES OF WEIRD THINGS FOR ME, AFTER THE SECOND VACCINE I FELT BAD FOR A FEW DAYS. FOLLOWING MONTH I FELT FATIGUED, GOT A BLADDER INFECTION AND NEW DIAGNOSED HEART MURMUR, RECIEVED ANTIBIOTICS, AND BLADDER INFECTION CLEARED, PRIMARY SAID A1C WAS AT 6.4, WHICH IS PREDIABETES, A1C BACK DOWN IN ANOTHER TEST.
big red blotch on injection site; it's really itchy; big red blotch on injection site; This is a spontaneous report from a sponsored program via a contactable consumer (patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received past drug BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Not reported, Expiration date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient experienced big red blotch on injection site and it was really itchy on an unspecified date. It was reported that she wanted to know if she can put ice on it. It was getting bigger. Her arm where she got was turned all red and itching like hell and it was driving her crazy. The outcome of the events was unknown.   No follow up attempts are needed. Information on lot/batch number cannot be obtained.
Initial misuse report received from a healthcare professional on 05 March 2013. ACTHIB was Reconstituted with sterile water and administered. No information was provided regarding the patients. No adverse event was reported. List of documents held by sender: none.
After about a week post vaccination I did see my symptoms begin to come back that was occurring prior to this vaccination post my 3rd dose of pfizer. I did not reach out to my dermatologist yet for care. I have just been using Minocycline to help with symptoms however my doctor did say that if my symptoms did not improve they would recommend hydroxychloroquine. I did previously have steroid injections on areas where my symptoms were raised, and I did see some improvement.
Moderna COVID-19 Vaccine EUA Four days after receiving the vaccine I had a fluttering heart for one day.
Rash (blister followed by flat large red patches) over extensive area Hives  also swelling (double) of lips  ew daysDiarrhea Had two separate reactions  separated by a few days relief
faint feeling, tightness in knees, itching started about a hour later then a rash or hives developed, later in evening patient developed fever and all over aching
pt recv vax 29NOV96 & varicella infect APR(7 unilateral acute retinal necrosis MAY97 thought secondary varicella infect;
She had onset of tinnitus in both ears 2 days after receiving the vaccine. The ringing in her ears has persisted.
Pain at injection site; no other adverse events; employee given .5 ml doses versus .25 ml dose
My left arm at injection sight It  was red and very itchy.  Below by approximately one inch was another red  area and it was itchy too,  they both had red lines extending from the red area. I put a cortisone cream on the areas and went to sleep.   When I awoke this morning it was still red and itchy.  I called my pharmacist to see if I could take Zyrtec liquid gels.  I was told to take one per day and to call my doctor to report it. The itching stopped and the red faded more at the injection site .  The redness below is still there although slightly lighter. It is now 5:17 pm on Feb. 14. 2021.
Within 15-minutes of vaccination, the patient had a syncopal event. EMS evaluated the patient on-site. The patient reported a history of syncope with the sight of needles and blood. EKG demonstrated sinus brady, rate 48 bpm, no ST elevation. The patient was hypertensive (155/88) and bradycardic. EMS administered 4mg Ondansetron PO. EMS transported the patient to Hospital Emergency Department. In the ED, the patient reported that they were currently asymptomatic after suffering a syncopal event following vaccination. The patient was normotensive (121/80). Given the patient's improvement in transit to the ED, the physician discharged the patient with a diagnosis of syncope.
Painful lymphadenopathy under arm where vaccine was administered. Erythema, pruritus, local ecchymosis, swelling at injection site. This occurred on day 7-8. treatment: tylenol, CBD clinic ointment, water
I had the initial Moderna COVID vaccines in Jan/Feb 2021. Menopause, specifically hot flashes several times a day, started shortly thereafter. Prior to the vaccines I was not showing signs of being perimenopausal. I began taking OTC supplement to help get some relief from the hot flashes. First booster Moderna in Nov 2021. Hot flashes continued and perhaps worsened. But consistent use of the supplements for the past year seemed be helping get them under control and I wasn't experiencing them nearly as often or as strongly. Another booster in September 2022. Hot flashes have returned WITH A VENEGENCE and now they're to the point that I'm breaking out in a sweat, in particular on my forehead, upper lip, nose. Since the onset of hot flashes in the winter of 2021, I would experience the rising flush of internal heat, but I never got sweaty. But following this most recent booster I am definitely noticing a marked difference in the strength of the hot flashes. I recently saw a news article about the study that did show a link between COVID vaccines and changes in young women's menstrual cycles. I had suspected that the initial vaccine had kick-started menopause for me (currently 49, nearly 50 years old) back in the winter of 2021, but this most recent booster has DEFINITELY affected the severity of the hot flashes and confirmed my suspicions. I do not regret getting the vaccine. If there are additional boosters, I will probably get them as well. I haven't heard anyone else talking about a link between kickstarting or worsening symptoms of menopause with the vaccine and I felt I should attempt to bring it to someone's attention.
rash on his torso/Rash on stomach; This case was reported by a consumer via call center representative and described the occurrence of rash in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th November 2019, the patient received the 1st dose of Shingrix. On 18th November 2019, 2 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had rash on his torso at the time of reporting. The patient clarified that the rash did not itch. The rash was on his torso, on the side of his stomach. The reporter did not consent to follow up.
Day after IZ given, pt had generalized rash. No rash at site of injection. No redness, swelling or discharge at injection site (L) deltoid.
No adverse event, reporting improper dosing sequence. Patient has now received 4 Shingrix shots in the past 14 months.
Breakthrough infection confirmed by antigen test, sore throat, stuffy nose, fever, upper respiratory congestion,.
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD 4/15/2023 BRIGHT RED BLOOD PER RECTUM G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, MILD 4/15/2023 SEVERE ALCOHOL USE DISORDER W ALCOHOL WITHDRAWAL, UNCOMPLICATED
Pain in left leg, complaints when walking, unexplained: Fevers, symptoms associated with cough (unknown skin irritants), back and neck aches!  No treatments issued at clinic, no records made or recorded!2/2/09-records received-3/14/03-received 2 month series of shots at 4 months during well baby visit with C/O dry skin. Routine visits parent has concerns related to multiple infections. History or viral and bacterial infections.
Sudden loss of what I was doing, going to do, had been doing. Confusion about what day it was, what was happening.  Later I had little memory of what had happened prior to being in the hospital.
Left arm numbness, tingling and decreased strength, elevated BP 142/100 Narrative:  See above symptoms. As of today 8/17/2021 employee is still awaiting further evaluation
Pt vaccinated with Fluzone developed painful stiff neck x5 days; No fever or other symptoms; No muscle ache or sensory nerve changes noticed.
Immunocompromised patient received booster dose for third dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Immunocompromised patient received booster dose for third dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Immunocompromised patient received booster dose for third dose). At the time of the report, ACCIDENTAL UNDERDOSE (Immunocompromised patient received booster dose for third dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Tested positive for COVID-19 with relative mild symptoms. Headache, runny nose, sore through. Normal temperature. Paxlovid 5 days.
Information has been received from a physician concerning a child who was vaccinated with Varivax. "In the past 2 weeks", in approximately March 2006, the patient experienced breakthrough chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Severe injection site pain began about four hours later, spread across to involve the whole shoulder. By evening it was pain level 8/10 and needed oxycodone for some relief (1 pill every 4 hours X3). Pain slowly improved over the next 48 hours and is now level 1-2.
Patient called complained of itching neck, back 2 small hives in hand with chest tightness. Patient was sent to ER for eval for chest tightness and feeling "closing" up.
We received the following information from a nurse via the agency on 05 FEB 2009: A 68-year-old woman, born on 26 APR 1940, was vaccinated with 0.5 ml FLUVIRIN, batch-no. 87924, i.m, on 10 NOV 2008. On 11 NOV 2008 the patient complained of soreness at injection site. On 12 NOV 2008 severe muscle and bone pain were reported. On 13 NOV 2008 she experienced shortness of breath which worsened and the patient was admitted to the hospital due to pneumonia on 14 NOV 2008. An antibiotic therapy started and she was discharged on 27 NOV 2008. Symptoms were resolved at time of report. Review of manufacturing protocols demonstrated that there were no deviations affecting product. No change in assessment.
Mom states child immediately upon leaving clinic developed redness at site which progressively became worse. Child developed fever and pain and itching at site. Child seen by local urgent care and primary care physician.
Body discomfort; Pain; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness). At the time of the report, DISCOMFORT (Body discomfort), PAIN (Pain) and FATIGUE (Tiredness) outcome was unknown.            No relevant concomitant medications were reported.  The patient did not receive any treatment.    Most recent FOLLOW-UP information incorporated above includes: On 27-Jun-2021: no significant information.
vomitting, diarrhea, abd pain reported to MD on 13APR92;